Medigen Biotechnology (ROCO:3176) 3-Year Revenue Growth Rate : 23.30% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology 3-Year Revenue Growth Rate?

Medigen Biotechnology's Revenue per Share for the three months ended in Dec. 2023 was NT$2.65.

During the past 12 months, Medigen Biotechnology's average Revenue per Share Growth Rate was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 23.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 29.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 26.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Medigen Biotechnology was 357.90% per year. The lowest was -42.10% per year. And the median was 12.80% per year.

Competitive Comparison of Medigen Biotechnology's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Medigen Biotechnology's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Biotechnology's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's 3-Year Revenue Growth Rate falls into.

Medigen Biotechnology 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Medigen Biotechnology (ROCO:3176) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Medigen Biotechnology 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Biotechnology (ROCO:3176) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560

Website

https://www.medigen.com.tw

Medigen Biotechnology Corp is a biopharmaceutical company primarily engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The new drug development business focuses mainly on the clinical stage of drug development and includes PI-88 MUPAFOSTAT for the treatment of liver cancer and OBP-301 treatment using adenovirus targeted to cancer cells only. Drug discovery includes the development of human-native mAbs for therapeutic applications related to infectious diseases. Generic drugs include pharmaceuticals for infectious diseases (antibiotics), contraceptives, nutrition milk powder, vitamin C tablets, dermatologic agents, and eye care products.

Medigen Biotechnology (ROCO:3176) Headlines

No Headlines